The Endothelial Glycocalyx in Pig-to-Baboon Cardiac Xenotransplantation-First Insights.

endothelial activation endothelial glycocalyx heart organ preservation orthotopic heart transplantation xenotransplantation

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
16 Jun 2024
Historique:
received: 07 05 2024
revised: 10 06 2024
accepted: 14 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Cardiac xenotransplantation has seen remarkable success in recent years and is emerging as the most promising alternative to human cardiac allotransplantation. Despite these achievements, acute vascular rejection still presents a challenge for long-term xenograft acceptance and new insights into innate and adaptive immune responses as well as detailed characterizations of signaling pathways are necessary. In allotransplantation, endothelial cells and their sugar-rich surface-the endothelial glycocalyx-are known to influence organ rejection. In xenotransplantation, however, only in vitro data exist on the role of the endothelial glycocalyx so far. Thus, in the current study, we analyzed the changes of the endothelial glycocalyx components hyaluronan, heparan sulfate and syndecan-1 after pig-to-baboon cardiac xenotransplantations in the perioperative (n = 4) and postoperative (n = 5) periods. These analyses provide first insights into changes of the endothelial glycocalyx after pig-to-baboon cardiac xenotransplantation and show that damage to the endothelial glycocalyx seems to be comparable or even less pronounced than in similar human settings when current strategies of cardiac xenotransplantation are applied. At the same time, data from the experiments where current strategies, like non-ischemic preservation, growth inhibition or porcine cytomegalovirus (a porcine roseolovirus (PCMV/PRV)) elimination could not be applied indicate that damage of the endothelial glycocalyx also plays an important role in cardiac xenotransplantation.

Identifiants

pubmed: 38927543
pii: biomedicines12061336
doi: 10.3390/biomedicines12061336
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : TRR 127
Organisme : Swiss National Science Foundation
ID : CR-SII5_198577
Pays : Switzerland
Organisme : Bavarian Research Foundation
ID : AZ-1543-22
Organisme : Fondation Leducq
ID : 23CVD01

Auteurs

Martin Bender (M)

Department of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.

Jan-Michael Abicht (JM)

Department of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.

Bruno Reichart (B)

Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.

Maria Leuschen (M)

Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.

Felicia Wall (F)

Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.

Julia Radan (J)

Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.

Elisabeth Neumann (E)

Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.

Maren Mokelke (M)

Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.

Ines Buttgereit (I)

Department of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.

Sebastian Michel (S)

Department of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.
Munich Heart Alliance, German Center for Cardiovascular Research (DZHK), 81377 Munich, Germany.

Reinhard Ellgass (R)

Department of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.

Katja Gieseke (K)

Department of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.

Stig Steen (S)

Department of Cardiothoracic Surgery, Lund University and Skåne University Hospital, 221 85 Lund, Sweden.

Audrius Paskevicius (A)

Department of Cardiothoracic Surgery, Lund University and Skåne University Hospital, 221 85 Lund, Sweden.

Joachim Denner (J)

Institute of Virology, Free University Berlin, 14163 Berlin, Germany.

Antonia W Godehardt (AW)

Division of Haematology, Cell and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.

Ralf R Tönjes (RR)

Division of Haematology, Cell and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.

Christian Hagl (C)

Department of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.
Munich Heart Alliance, German Center for Cardiovascular Research (DZHK), 81377 Munich, Germany.

David Ayares (D)

Revivicor, Blacksburg, VA 24060, USA.

Eckhard Wolf (E)

Institute of Molecular Animal Breeding and Biotechnology, Gene Center, and Department of Veterinary Sciences, LMU Munich, 81377 Munich, Germany.
Center for Innovative Medical Models (CiMM), LMU Munich, 81377 Munich, Germany.
Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, 81377 Munich, Germany.

Michael Schmoeckel (M)

Department of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.

Paolo Brenner (P)

Department of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.

Martin B Müller (MB)

Department of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.

Matthias Längin (M)

Department of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.

Classifications MeSH